Carthera

Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera has developed a proprietary device called SonoCloud- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimers Disease, ALS). The products developed by Carthera are in clinical or preclinical evaluation...

Medical devices,neurosurgery,therapeutic ultrasound,and neuro-oncology

Carthera operates in the Medical equipment manufacturing industry.

Carthera's revenue is 11m - 100m

Carthera has 11 - 50 employees.